首页> 美国卫生研究院文献>Molecular and Cellular Biology >Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions
【2h】

Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions

机译:诱导的活性氧物种对p53介导的细胞命运决定的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The p53 tumor suppressor gene can induce either apoptosis or a permanent growth arrest (also termed senescence) phenotype in response to cellular stresses. We show that the increase in intracellular reactive oxygen species (ROS) associated with the magnitude of p53 protein expression correlated with the induction of either senescence or apoptosis in both normal and cancer cells. ROS inhibitors ameliorated both p53-dependent cell fates, implicating ROS accumulation as an effector in each case. The absence of Bax or PUMA strongly inhibited both p53-induced apoptosis and ROS increase, indicating an important role these p53 targets affecting mitochondrial function genes in p53-mediated ROS accumulation. Moreover, physiological p53 levels in combination with an exogenous ROS source were able to convert a p53 senescence response into apoptosis. All of these findings establish a critical role of ROS accumulation and mitochondrial function in p53-dependent cell fates and show that other ROS inducers can collaborate with p53 to influence these fate decisions. Thus, our studies imply that therapeutic agents that generate ROS are more likely to be toxic for normal cells than p53-negative tumor cells and provide a rationale for identifying therapeutic agents that do not complement p53 in ROS generation to ameliorate the cytotoxic side effects in normal cells.
机译:p53抑癌基因可以响应细胞应激而诱导凋亡或永久性生长停滞(也称为衰老)表型。我们显示与p53蛋白表达的大小相关的细胞内活性氧(ROS)的增加与正常和癌细胞中衰老或凋亡的诱导相关。 ROS抑制剂改善了p53依赖性细胞的命运,在每种情况下都暗示ROS积累为效应子。 Bax或PUMA的缺失强烈抑制了p53诱导的细胞凋亡和ROS的增加,表明这些p53靶标在p53介导的ROS积累中影响线粒体功能基因,具有重要作用。而且,生理学p53水平与外源性ROS源的结合能够将p53衰老反应转化为凋亡。所有这些发现建立了ROS积累和线粒体功能在p53依赖的细胞命运中的关键作用,并表明其他ROS诱导剂可以与p53协同影响这些命运的决定。因此,我们的研究表明,产生ROS的治疗剂比p53阴性肿瘤细胞对正常细胞更可能具有毒性,并为鉴定在ROS产生中不补充p53的治疗剂提供了理论依据,以减轻正常情况下的细胞毒副作用。细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号